Beauty platform company CTK announced on the 11th that it has decided to make a strategic investment in CDRI, a global cosmetics approval platform operator based on big data and AI.


Founded in 2020, CDRI is a beauty IT solution company that combines cosmetics big data with AI technology to provide cosmetics approval procedures and clinical trial automation much faster and at a lower cost than before. It has experience handling over 3,500 approval applications across 36 countries for more than 600 beauty companies.


CTK decided to proceed with strategic investment and collaboration to provide advanced automated services to CTKCLIP customers based on CDRI’s big data and blockchain technologies. The CTKCLIP platform operated by CTK offers turnkey solutions covering everything in beauty from cosmetics planning to development and production. It serves global beauty companies not only in Asia but also in the United States and Europe.


Since regulations and approval structures vary greatly and are complex across countries and markets, accurate and precise design is essential to develop and launch cosmetics accordingly. The customized solution CTK will develop with CDRI aims to enable advanced automated approval applications based on AI tailored to demand. It seeks to provide optimized solutions for CTKCLIP’s customer-tailored services from the planning and development stages to UX and UI.



Jin-Yong Jeong, CEO of CTK, explained, "As the global new customer base for CTKCLIP has greatly expanded recently, regulatory requirements have increased accordingly. Through synergy with the CDRI platform, we will provide faster and more accurate services."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing